372 related articles for article (PubMed ID: 17618857)
1. Dissociation of hepatic steatosis and insulin resistance in mice overexpressing DGAT in the liver.
Monetti M; Levin MC; Watt MJ; Sajan MP; Marmor S; Hubbard BK; Stevens RD; Bain JR; Newgard CB; Farese RV; Hevener AL; Farese RV
Cell Metab; 2007 Jul; 6(1):69-78. PubMed ID: 17618857
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte Deletion of Triglyceride-Synthesis Enzyme Acyl CoA: Diacylglycerol Acyltransferase 2 Reduces Steatosis Without Increasing Inflammation or Fibrosis in Mice.
Gluchowski NL; Gabriel KR; Chitraju C; Bronson RT; Mejhert N; Boland S; Wang K; Lai ZW; Farese RV; Walther TC
Hepatology; 2019 Dec; 70(6):1972-1985. PubMed ID: 31081165
[TBL] [Abstract][Full Text] [Related]
3. Mitochondrial dysfunction due to long-chain Acyl-CoA dehydrogenase deficiency causes hepatic steatosis and hepatic insulin resistance.
Zhang D; Liu ZX; Choi CS; Tian L; Kibbey R; Dong J; Cline GW; Wood PA; Shulman GI
Proc Natl Acad Sci U S A; 2007 Oct; 104(43):17075-80. PubMed ID: 17940018
[TBL] [Abstract][Full Text] [Related]
4. Glycerol-3-phosphate acyltransferase 1 deficiency in ob/ob mice diminishes hepatic steatosis but does not protect against insulin resistance or obesity.
Wendel AA; Li LO; Li Y; Cline GW; Shulman GI; Coleman RA
Diabetes; 2010 Jun; 59(6):1321-9. PubMed ID: 20200319
[TBL] [Abstract][Full Text] [Related]
5. DGAT2 inhibition blocks SREBP-1 cleavage and improves hepatic steatosis by increasing phosphatidylethanolamine in the ER.
Rong S; Xia M; Vale G; Wang S; Kim CW; Li S; McDonald JG; Radhakrishnan A; Horton JD
Cell Metab; 2024 Mar; 36(3):617-629.e7. PubMed ID: 38340721
[TBL] [Abstract][Full Text] [Related]
6. The roles of DGAT1 and DGAT2 in human myotubes are dependent on donor patho-physiological background.
Irshad Z; Lund J; Sillars A; Løvsletten NG; Gharanei S; Salt IP; Freeman DJ; Gill JMR; Thoresen GH; Rustan AC; Zammit VA
FASEB J; 2023 Nov; 37(11):e23209. PubMed ID: 37779421
[TBL] [Abstract][Full Text] [Related]
7. Increased insulin and leptin sensitivity in mice lacking acyl CoA:diacylglycerol acyltransferase 1.
Chen HC; Smith SJ; Ladha Z; Jensen DR; Ferreira LD; Pulawa LK; McGuire JG; Pitas RE; Eckel RH; Farese RV
J Clin Invest; 2002 Apr; 109(8):1049-55. PubMed ID: 11956242
[TBL] [Abstract][Full Text] [Related]
8. Transgenic Overexpression of HDAC9 Promotes Adipocyte Hypertrophy, Insulin Resistance and Hepatic Steatosis in Aging Mice.
Veerapaneni P; Goo B; Ahmadieh S; Shi H; Kim DS; Ogbi M; Cave S; Chouhaita R; Cyriac N; Fulton DJ; Verin AD; Chen W; Lei Y; Lu XY; Kim HW; Weintraub NL
Biomolecules; 2024 Apr; 14(4):. PubMed ID: 38672510
[TBL] [Abstract][Full Text] [Related]
9. Acyl ghrelin, desacyl ghrelin and their ratio affect hepatic steatosis via PPARγ signaling pathway.
Elibol E; Akdevelioğlu Y; Yılmaz C; Narlı B; Şen S; Take Kaplanoğlu G; Seymen CM
Arab J Gastroenterol; 2024 May; 25(2):109-117. PubMed ID: 38383264
[TBL] [Abstract][Full Text] [Related]
10. Genetic regulation of liver lipids in a mouse model of insulin resistance and hepatic steatosis.
Norheim F; Chella Krishnan K; Bjellaas T; Vergnes L; Pan C; Parks BW; Meng Y; Lang J; Ward JA; Reue K; Mehrabian M; Gundersen TE; Péterfy M; Dalen KT; Drevon CA; Hui ST; Lusis AJ; Seldin MM
Mol Syst Biol; 2021 Jan; 17(1):e9684. PubMed ID: 33417276
[TBL] [Abstract][Full Text] [Related]
11. The loss of P2X7 receptor expression leads to increase intestinal glucose transit and hepatic steatosis.
Arguin G; Bourzac JF; Placet M; Molle CM; Paquette M; Beaudoin JF; Rousseau JA; Lecomte R; Plourde M; Gendron FP
Sci Rep; 2017 Oct; 7(1):12917. PubMed ID: 29018292
[TBL] [Abstract][Full Text] [Related]
12. Lipid signals and insulin resistance.
Zhang C; Klett EL; Coleman RA
Clin Lipidol; 2013 Dec; 8(6):659-667. PubMed ID: 24533033
[TBL] [Abstract][Full Text] [Related]
13. Nonalcoholic fatty liver disease, hepatic insulin resistance, and type 2 diabetes.
Birkenfeld AL; Shulman GI
Hepatology; 2014 Feb; 59(2):713-23. PubMed ID: 23929732
[TBL] [Abstract][Full Text] [Related]
14. Hepatic steatosis: a role for de novo lipogenesis and the transcription factor SREBP-1c.
Ferré P; Foufelle F
Diabetes Obes Metab; 2010 Oct; 12 Suppl 2():83-92. PubMed ID: 21029304
[TBL] [Abstract][Full Text] [Related]
15. The SREBP pathway: regulation of cholesterol metabolism by proteolysis of a membrane-bound transcription factor.
Brown MS; Goldstein JL
Cell; 1997 May; 89(3):331-40. PubMed ID: 9150132
[No Abstract] [Full Text] [Related]
16. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.
Jornayvaz FR; Birkenfeld AL; Jurczak MJ; Kanda S; Guigni BA; Jiang DC; Zhang D; Lee HY; Samuel VT; Shulman GI
Proc Natl Acad Sci U S A; 2011 Apr; 108(14):5748-52. PubMed ID: 21436037
[TBL] [Abstract][Full Text] [Related]
17. Lipid droplets induced by secreted phospholipase A
Jarc E; Kump A; Malavašič P; Eichmann TO; Zimmermann R; Petan T
Biochim Biophys Acta Mol Cell Biol Lipids; 2018 Mar; 1863(3):247-265. PubMed ID: 29229414
[TBL] [Abstract][Full Text] [Related]
18. Intratumor cholesteryl ester accumulation is associated with human breast cancer proliferation and aggressive potential: a molecular and clinicopathological study.
de Gonzalo-Calvo D; López-Vilaró L; Nasarre L; Perez-Olabarria M; Vázquez T; Escuin D; Badimon L; Barnadas A; Lerma E; Llorente-Cortés V
BMC Cancer; 2015 Jun; 15():460. PubMed ID: 26055977
[TBL] [Abstract][Full Text] [Related]
19. Migration of MDA-MB-231 breast cancer cells depends on the availability of exogenous lipids and cholesterol esterification.
Antalis CJ; Uchida A; Buhman KK; Siddiqui RA
Clin Exp Metastasis; 2011 Dec; 28(8):733-41. PubMed ID: 21744083
[TBL] [Abstract][Full Text] [Related]
20. Cardiomyocyte lipids impair β-adrenergic receptor function via PKC activation.
Drosatos K; Bharadwaj KG; Lymperopoulos A; Ikeda S; Khan R; Hu Y; Agarwal R; Yu S; Jiang H; Steinberg SF; Blaner WS; Koch WJ; Goldberg IJ
Am J Physiol Endocrinol Metab; 2011 Mar; 300(3):E489-99. PubMed ID: 21139071
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
